Speaker presentations

Carsten Reidies Bjarkam is senior consultant and professor in neurosurgery at Aalborg University Hospital Denmark. He is a subspecialized spine surgeon focusing on the use of minimal invasive nervous decompression techniques in the treatment of elderly patients with degenerative spine disease. He is a board member of the Scandinavian and the Danish Neurosurgical Societies, and he has for many years enjoyed teaching the coming generations of Scandinavian neurosurgeons at the yearly Beitostollen course in Norway.

Juhana Frösén, Professor of Neurosurgery at Tampere University and University Hospital has studied the vascular biology of vessel remodeling for more than 25-years, translating this knowledge into major advances in our understanding of aneurysm formation, growth, and eventual rupture, as well as the formation, growth, and rupture of brain AVMs (arteriovenousmalformations). Prof. Frösen is most known for his work on the pathology of the intracranial aneurysm wall, and the association of aneurysm wall remodeling with inflammation and flow conditions. Prof. Frösén develops pharmaceutical therapy for intracranial aneurysms and bAVMs, in addition to treating these diseases microsurgically.

Together with a multidisciplinary team at the Tampere University, Prof. Frösén aims to develop data-driven and knowledge-driven decision support tools to help patients with intracranial aneurysms, bAVMs, or other cerebrovascular pathologies with hemorrhagic potential, to make informed decisions that are best for them.

In addition to working on improving predictive diagnostics, patient-centered decision-support tools, and the treatments of neurosurgical disease, developing the training of the next generation of neurosurgeons is close to the heart of Prof. Frösén.

Jaakko Kaprio, M.D., Ph.D. is a Research Director at the Institute for Molecular Medicine FIMM, University of Helsinki and was Professor of Genetic Epidemiology, University of Helsinki, Finland from 2001 until mandatory retirement in April 2020. He held a five-year research professorship fully funded by the Academy of Finland from 2013 to 2017. The Academy Professorship research theme was on genetics, epigenetics and epidemiology of smoking and nicotine dependence. He was Director of FIMM from Oct 1, 2015 to January 31, 2018; FIMM is an EMBL-associated biomedical research institute focusing on personalized cancer therapies, large-scale genetics studies (such as FinnGen) and use of AI in digital pathology.

Dr. Kaprio has worked in genetic epidemiology with a focus on risk factors of non-communicable disease, especially smoking and alcohol use and dependence. He has worked with the Finnish Twin Cohort studies since 1976, and with other population-based samples in Finland. He has engaged in extensive international collaborations, including multiple NIH and EU funded projects. He has served as President of the Society for Research on Nicotine and Tobacco European chapter, as President of the Behavior Genetics Association and as President of the International Society for Twin Studies. He has been active in cancer and tobacco-related NGOs in Finland. He has supervised 55 PhD students, and published over 1500 peer-reviewed articles.

Julia Lindlöf, RN, PhD, is a registered nurse and university teacher at the University of Eastern Finland. She has over ten years of clinical experience in neurosurgical nursing at the Department of Neurosurgery, Helsinki University Hospital, Finland.

In addition to her clinical and academic work, Lindlöf has worked as a project coordinator at the Finnish Brain Injury Association, focusing on improving support for family members of individuals with traumatic brain injury (TBI) during acute care.

Her doctoral dissertation, Empowering Support Framework for Family Members of Individuals with Traumatic Brain Injury – a mixed-methods study (2025), developed an Empowering Support Framework (ESF) to support family members in neurosurgical and neurological acute care settings and evaluated its applicability in nursing practice from the perspective of registered nurses.

Lindlöf’s research and professional interests focus on family-centred care and the role of family members in supporting patient participation during acute neuro care. She is particularly interested in developing more equitable and systematic nursing practices to ensure that family members receive consistent support regardless of the care setting.

Dr. Ivan Radovanovic is an open vascular neurosurgeon, and a professor and research scientist at the Krembil Institute at Toronto University. His clinical interests include the treatment of cerebrovascular pathologies with hemorrhagic potential, and his research activities also include the study of the pathological mechanisms driving these diseases. His research group has made fundamental discoveries on the pathogenesis of brain AVMs, opening new possibilities for drug therapy of these lesions.

Prof. Michihiro Tanaka is a Japanese neurosurgeon and neurointerventional pioneer, Director of the Neurocenter, Neurosurgery and Neuroendovascular Surgery at Kameda Medical Center in Chiba, and former President (2022-2024) of the World Federation of Interventional and Therapeutic Neuroradiology (WFITN). Trained in Osaka, Yokohama and at the University Hospital of Zürich under mentor Prof. Anton Valavanis, he combines microneurosurgery with advanced endovascular therapy. His specialty is neuroendovascular surgery grounded in functional vascular anatomy and embryology, treating intracranial aneurysms, brain AVMs, dural AVFs and spinal cord vascular malformations using high resolution imaging modalities. Known internationally for work on the angioarchitecture and developmental origin of AVMs and dAVFs, he has helped refine risk assessment and minimally invasive strategies for complex cerebrovascular and skull-base disease while training the next generation of neurovascular specialists.

Constantin Tuleasca, MD-PhD, currently works as a neurosurgeon in Clinique de La Source and Swiss Medical Network in Lausanne, Switzerland. He is also Associate Professor of Neurosurgery at the University of Medicine and Pharmacy “Gr. T. Popa” in Iași, Romania.

A clinician–scientist, he completed his neurosurgical training at Lausanne University Hospital (CHUV, 2007-2025), complemented by three international fellowships: stereotactic radiosurgery in Marseille (Prof. Régis, 2010-2011), intramedullary tumors and rare spinal malformations in Paris (Prof. Parker, 2018-2019), and neuro-oncology/spinal surgery in Lille (Prof. Reyns, 2019-2020).

Dr. Tuleasca obtained his MD–PhD from the University of Lausanne in 2018, receiving the Excellence Prize in 2019. He is Swiss Board certified in Neurosurgery since 2019. He has authored or co-authored more than 160 peer-reviewed papers in leading scientific journals and served as a staff neurosurgeon at the public hospital in Lausanne (CHUV) between 2022 and 2025.
His contributions have been recognized with several prestigious honors, including the Young Professional Award of the International Stereotactic Radiosurgery Society (ISRS), two distinctions from the French Academy of Medicine (Paris), and awards from the European Association of Neurosurgical Societies (EANS). He also served as a member of the ISRS Board (2019–2025). He is currently a member of the Radiosurgery and Frontiers panels in the EANS.

Mark van Gils is Professor of Digital Healthcare, leading the research group Decision Support for Health, at Tampere University and Adjunct Professor in physiological signal processing at Aalto University. Activities in his over 25-year career in health data analysis have ranged from AI-driven patient monitoring in critical care to preventive approaches during daily living. He has special interest in data-driven approaches that take into account real-life challenges, such as dealing with imperfect data, heterogeneity of data sources, and ambiguity in outcomes. He has worked tightly with renowned university hospitals and health tech companies, and he has obtained extensive experience in carrying out leading roles, including coordination, in multi-disciplinary international research consortia, such as in EU projects.

Dr. Wakhloo earned both his MD and PhD in endocrinology and metabolic disorders from the University of Mainz, Germany. He completed fellowships in diagnostic and interventional neuroradiology, as well as endovascular neurosurgery, at the University of Freiburg, SUNY Buffalo, and the BNI in Phoenix. In 1995, he was awarded the venia legendi from the University of Tübingen, Germany, for his research and thesis on flow diversion for brain aneurysms. He served as an Associate Professor in the Department of Neurosurgery at SUNY Buffalo (1995-1999), a Professor of Radiology, Neurology, and Neurosurgery at the University of Miami (1999–2005), and Professor and Chief of Neurointervention and Neuroimaging at the University of Massachusetts Medical School (2005–2018) and at the Beth Israel Lahey Clinic, Boston (2018–2023).

He currently holds the position of Professor at Tufts University School of Medicine and serves as CMO and CEO for various start-ups. His groundbreaking contributions have earned him numerous scientific awards from the Whitaker Bioengineering Research Foundation, the German Society of Neuroradiology, and the Society of Vascular Interventional Neurology Innovation. He was named a Fellow of the AHA and Stroke Council and a Fellow of the Society for Neurointerventional Surgery. Renowned as the father of flow diversion, Dr. Wakhloo was the first to introduce the concept in 1989. His pioneering work also extended to stent retriever thrombectomy for acute ischemic stroke, published in 2008. Holding multiple U.S. patents for neurovascular devices, he has been at the forefront of innovation. Dr. Wakhloo has served on editorial boards of major medical journals, played key advisory roles in Medtech companies, and secured private and federal research funding as a PI and Co-Investigator on numerous grants from NIH and industry. With over 500 peer-reviewed publications, book chapters, and scientific articles, he continues to advance the field of neurovascular medicine.